Skip to content

22q Partial Monosomy C0265489

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder from missing material on chromosome 22, often called DiGeorge syndrome. It can affect the heart, immune system, and development. Requires lifelong specialized medical care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Congenital heart defects

Structural abnormalities of the heart present at birth, commonly including tetralogy of Fallot, ventricular septal defects, and truncus arteriosus.

Seek immediate medical attention if symptoms of heart failure develop, including rapid breathing, difficulty feeding, or bluish skin coloration.

!

Hypocalcemia

Low blood calcium levels due to underdeveloped parathyroid glands, causing muscle cramps, tingling, and seizures.

Seek emergency care if experiencing severe muscle cramps, tetany, confusion, or seizures.

!

Seizures

Epileptic episodes that may be related to hypocalcemia, structural brain abnormalities, or idiopathic causes.

Seek emergency care for any new-onset seizure activity.

Cleft palate

(gastrointestinal)

Opening or split in the roof of the mouth that may involve the soft palate and sometimes the hard palate.

Frequency: 30-50% of patients

Facial dysmorphism

(constitutional)

Distinctive facial features including wide-set eyes, small ears, flattened midface, and thin lips.

Frequency: 80-90% of patients

Developmental delay

(neurologic)

Delayed achievement of developmental milestones including motor skills, speech, and cognitive development.

Frequency: 70-90% of patients

Feeding difficulties

(gastrointestinal)

Problems with feeding and swallowing due to cleft palate, low muscle tone, or sensory issues.

Frequency: 40-50% of patients

Immunodeficiency

(constitutional)

Reduced immune function due to T-cell deficiency, leading to increased susceptibility to infections.

Frequency: 75-80% of patients

Renal anomalies

(gastrointestinal)

Kidney abnormalities including absent, horseshoe, or dysplastic kidneys, often detected on prenatal ultrasound.

Frequency: 30-40% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunological function monitoring

Regular assessment of T-cell function and immunoglobulin levels due to thymic hypoplasia associated with 22q partial monosomy. Frequency based on baseline immune function and clinical status.

monitoring
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Cardiac defect surgical repair

Surgical intervention for conotruncal heart defects and vascular anomalies characteristic of partial 22q monosomy. Procedures range from catheter-based interventions to open heart surgery depending on defect complexity.

surgical

Additional treatment options

Calcium and mineral supplementation monitoring

Assessment and management of hypocalcemia through dietary evaluation and supplementation when indicated. Regular calcium and vitamin D level monitoring guides supplementation needs.

dietary

Developmental and occupational therapy

Comprehensive therapy addressing developmental delays, feeding difficulties, and fine/gross motor skill development. Early intervention is particularly important for speech and language development.

physical_therapy

Psychiatric and behavioral intervention

Assessment and treatment of psychiatric manifestations including anxiety, depression, and schizophrenia-spectrum disorders. Medication management combined with psychotherapy provides comprehensive care.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 22q Partial Monosomy C0265489?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American Academy of Pediatrics. Health Care Supervision for Children with 22q11.2 Deletion Syndrome. Pediatrics. 2012;129(5):e1526-e1536.

guideline2012View source →
2

McDonald-McGinn DM, Sullivan KE, Marino B, et al. 22q11.2 Deletion Syndrome. Nat Rev Dis Primers. 2021;7(1):64.

review2021View source →
3

Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical Guidelines for Managing Patients with 22q11.2 Deletion Syndrome. J Pediatr. 2011;159(2):332-339.e1.

consensus2011View source →
4

Philip N, Bassett AS. Cognitive, Behavioral, and Psychiatric Phenotypes in 22q11.2 Deletion Syndrome. Curr Opin Psychiatry. 2011;24(3):239-246.

review2011View source →
5

Wenger TL, Miller JS, DePolo LM, et al. 22q11.2 Deletion Syndrome and Autism Spectrum Disorder: A Meta-analysis. Mol Autism. 2020;11(1):66.

meta_analysis2020View source →
6

Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews [Internet]. 22q11.2 Deletion Syndrome. Seattle (WA): University of Washington; 1993-2024.

textbook2024View source →
7

Fung WLA, Butcher NJ, Costain G, et al. Breastfeeding Outcomes Among Women with 22q11.2 Deletion Syndrome. J Pediatr. 2016;178:206-210.

clinical_trial2016View source →
8

International Society of Psychiatric Genetics. Position Statement on 22q11.2 Deletion Syndrome and Psychiatric Disorders. 2019.

position_statement2019View source →
9

Cancrini C, Puttur F, Ma CS, et al. Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency: 22q11.2 Deletion Syndrome. J Allergy Clin Immunol. 2021;147(5):1699-1707.

review2021View source →
10

European Society of Human Genetics. Clinical Utility of Genetic Testing in 22q11.2 Deletion Syndrome. Eur J Hum Genet. 2023;31(5):529-537.

guideline2023View source →

Medication Comparisons

Compare medications used to treat 22q Partial Monosomy C0265489. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy